
Home » Genetron Health Gains CE Mark for COVID-19 Test
Genetron Health Gains CE Mark for COVID-19 Test

Beijing-based Genetron Health has received a CE Mark for its novel coronavirus detection kit.
The polymerase chain-reaction test is designed for use with the company’s Genetron S5 sequencer for testing large-scale samples.
The company has also applied to the FDA for emergency use authorization.
Upcoming Events
-
08Sep
-
15Sep
-
20Sep
-
21Sep
-
22Sep
-
11Oct